Literature DB >> 30032127

Different immunoreactivity of monomers and dimers makes automated free light chains assays not equivalent.

Laura Caponi1, Elona Koni1, Nadia Romiti1, Aldo Paolicchi1, Maria Franzini1.   

Abstract

Background The automated immunochemical serum free light chains (FLC) assays, Freelite (a polyclonal antiserum) and N Latex FLC (a mixture of monoclonal antibodies), are not interchangeable, as they may provide different results on a same sample. This study was aimed to establish if the calibrators contain FLC oligomers, and if different reactivity against monomers and dimers contributes to the discrepancy. Methods Gel filtration chromatography fractions of the calibrators were subjected to a Western blot (WB) and analyzed by each reagent. The procedure was repeated after pretreating the N Latex FLC calibrator with the reducing agent dithiothreitol (DTT). Results Both calibrators contain FLC dimers and monomers. Both reagents detect (with different sensitivity) FLC kappa monomers and dimers; instead, Freelite detects only FLC lambda dimers, while N Latex FLC detects only FLC monomers. After DTT treatment, only the N Latex lambda still detects FLC with reduced protein thiols, while the reactivity of all other reagents is abolished. Conclusions Due to their different reactivity against FLC monomers and oligomers, the Freelite and N Latex FLC are calibrated against different components of their own calibrators, making the two reagents not equivalent. The redox status of FLC determines the immunoreactivity not only of FLC dimers, but also of the monomers.

Entities:  

Keywords:  disulfide bonds; free light chains; monoclonal gammopathies; monomers and oligomers

Mesh:

Substances:

Year:  2018        PMID: 30032127     DOI: 10.1515/cclm-2018-0412

Source DB:  PubMed          Journal:  Clin Chem Lab Med        ISSN: 1434-6621            Impact factor:   3.694


  4 in total

1.  A method to obtain purified free light chain monomers and dimers from urine samples of patients with multiple myeloma.

Authors:  Laura Caponi; Alice Botti; Nadia Romiti; Aldo Paolicchi; Maria Franzini
Journal:  Immunol Res       Date:  2022-09-14       Impact factor: 4.505

2.  Comparison of 2 Serum-Free Light-Chain Assays in CKD Patients.

Authors:  Ben Sprangers; Kathleen Claes; Pieter Evenepoel; Dirk Kuypers; Koen Poesen; Michel Delforge; Xavier Bossuyt V; Björn Meijers
Journal:  Kidney Int Rep       Date:  2020-01-30

3.  Using Two Detection Methods to Observe the Changes and Significance of Free Light Chain in Serum and Urine in Patients with Renal Insufficiency.

Authors:  Lengnan Xu; Ban Zhao; Ying Sun; Songlan Wang; Xianguang Chen; Yonghui Mao
Journal:  Biomed Res Int       Date:  2022-03-29       Impact factor: 3.411

Review 4.  Free Light Chains as a Novel Diagnostic Biomarker of Immune System Abnormalities in Multiple Sclerosis and HIV Infection.

Authors:  Monika Gudowska-Sawczuk; Barbara Mroczko
Journal:  Biomed Res Int       Date:  2019-12-09       Impact factor: 3.411

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.